Late-stage trial meets primary endpoint! Eli Lilly (LLY.US) plans to expand Omvoh indication for the treatment of pediatric ulcerative colitis

Zhitong Finance APP has learned that Eli Lilly (LLY.US) announced on Monday that after a late-stage trial of Omvoh injection in pediatric patients with ulcerative colitis achieved success, the company plans to seek to expand the indication for this intestinal disease therapy.